Opioid Use Disorder Market Insights and Epidemiology Forecast

1. Opioid Use Disorder Market Size Analysis, Growth Opportunities, Pipeline Development Activities, and Emerging Therapies Opioid Use Disorder Opioids, generally prescribed as pain relievers, are natural or synthetic chemicals that bind to opioid receptors in the central nervous system and can reduce feelings of pain. Along with the depressant effect on the CNS, they also have the potential to cause euphoria. Misuse or overdose of prescribed opioid medications refers to ‘Opioid use disorder (OUD) ‘. Opioid use disorders affect over 16 million people worldwide, over 2.1 million in the United States, and there are over 120,000 deaths worldwide annually attributed to opioids. Two types of patients suffer from OUD: those addicted to non-medical opioids and those addicted to medical opioids. OUD is a chronic disorder that usually requires both medications for opioid use disorder and psychosocial treatment and support. Current treatments are based on medication-assisted treatment (MAT) with an opioid agonist or

2. an opioid antagonist. Most commonly abused opioids are codeine, oxycodone, hydrocodone, morphine, and fentanyl. Physical dependence is the most harmful long-term effect, and withdrawal symptoms occur if opioid use is abruptly reduced. DelveInsight’s “Opioid Use Disorder Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Opioid Use Disorder, historical and forecasted epidemiology as well as the Opioid Use Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the key facts of the Opioid Use Disorder Market Report: ● Opioid use disorders affect over 16 million people worldwide, over 2.1 million in the United States, and there are over 1,20,000 deaths worldwide annually attributed to opioids The prevalence of opioid use and dependency varies by age and gender. Men are more likely to use opioids, become dependent on various opioids, and they account for the majority of opioid-related overdoses According to the CDC, the age-adjusted drug poisoning death rate involving opioid analgesics increased to 7.0 per 100000, mounting to the deaths of over 15,000 people due to heroin overdose in 2017 According to the World Health Organization (WHO), the annual global prevalent pool of opioid abusers was estimated at between 28 and 38 million users Opioid dependence includes physical or psychological dependence or both. The majority of opioids in use are prescribed, but many are obtained illegally ● ● ● ● Request a sample for the Opioid Use Disorder Market Report: Opioid Use Disorder Symptoms: The symptoms of Opioid Use Disorder include – ● ● ● ● Constipation Nausea and vomiting Mental Fog Drowsiness Epidemiology Segmentation of Opioid Use Disorder: ● ● ● ● Prevalent Cases of Opioid Use Disorder in the 7MM [2019-2032] Age-Specific Cases of Opioid Use Disorder in the 7MM [2019–2032] Gender-Specific Cases of Opioid Use Disorder in the 7MM [2019–2032] Diagnosed and Treated Cases of Opioid Use Disorder in the 7MM [2019–2032] Opioid Use Disorder Market The dynamics of the Opioid Use Disorder market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as RBP-6000, ASP8062, and others during the forecasted period 2019-2032.

3. Learn more by requesting for sample @ Opioid Use Disorder Market Landscape Opioid Use Disorder Pipeline Therapies: ● ● ● ● RBP-6000 ASP8062 Methadone Naltrexone Opioid Use Disorder Pipeline Key Companies: ● ● ● ● Alkermes, Inc. Lyndra Inc. Astellas Pharma Braeburn Pharmaceuticals Related Reports: Diagnostic Imaging Equipment Market Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases. Invasive Candidiasis Market "DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW. Sialidosis Market DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Filgrastim Biosimilar Insight DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

4. Pain Management Devices Market Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027 Latest Reports by DelveInsight Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market To know more about our Competitive Services, Click here: Pharma Competitive Intelligence